Download PDF
Ultraschall Med 2020; 41(06): 658-667
DOI: 10.1055/a-0902-4842
Original Article
Thieme. All rights reserved. (2020) Georg Thieme Verlag KG

Color Duplex Doppler US can Follow up the Response of Radioiodine in Graves’ Disease by Evaluating the Thyroid Volume and Peak Systolic Velocity

Farbduplex-Doppler-US kann das Ansprechen auf Radiojodtherapie bei Morbus Basedow mittels Schilddrüsenvolumen und maximaler systolischer Geschwindigkeit bewerten
Thiago Adler Ralho Rodrigues Santos
1   Radiology Institute, Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
,
Suemi Marui
2   Laboratory of Cellular and Molecular Endocrinology (LIM 25), Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
,
Tomoco Watanabe
1   Radiology Institute, Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
,
Nicolau Lima
3   Endocrinology Institute, Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
,
Claudia Okanobo Ozaki
4   Nuclear-Medicine, SONIMED diagnostic medicine, Campo Grande, Brazil
,
Giovanni Guido Cerri
1   Radiology Institute, Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
,
Maria C. Chammas
1   Radiology Institute, Clinical Hospital of the Medical School of the University of São Paulo, Sao Paulo, Brazil
› Author Affiliations
Further Information

Publication History

29 March 2018

09 April 2019

Publication Date:
28 May 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Purpose The objective of this study was to prove the efficacy of Doppler ultrasonography (US-Doppler) in the follow-up of patients with GD treated with radioactive iodine.

Methods 97 patients (77 female and 20 male) with a mean age of 42 years (SD ± 15) and with prior diagnosis of GD were treated with radioiodine. In total, 88.5 % achieved euthyroidism or hypothyroidism after treatment. The study was documented before treatment and one, three, and six months after treatment with radioactive iodine (131I) by a single investigator. The volume, echogenicity, echotexture and vascularization of the glands as well as the peak systolic velocity (PSV) of the inferior thyroid arteries were evaluated and compared with the laboratory data.

Results Thyroid volume and PSV had a statistically significant correlation with hormone levels (p < 0.05). The mean pre-dose therapeutic thyroid volume was 43.01 ± 3.88 cm3 and was 11.58 ± 11.26 cm3 6 months after treatment. The mean PSV before 131I was 90.06 ± 44.13 cm/s and decreased significantly over time (p < 0.001). Six months after the therapeutic dose, the mean PSV was 32.95 ± 16.36 cm/s. However, the subjective parameters did not have a significant correlation with the normalization of the thyroid hormones.

Conclusion Doppler US was useful for monitoring the therapeutic response of GD patients after treatment with radioiodine by evaluating the thyroid volume and peak systolic velocity.

Zusammenfassung

Ziel Das Ziel dieser Studie war es, die Leistungsfähigkeit der Dopplersonografie (US-Doppler) in der Nachbeobachtung von Patienten mit Morbus Basedow nach Radiojodtherapie zu überprüfen.

Material und Methoden 97 Patienten (77 Frauen und 20 Männer) mit einem Durchschnittsalter von 42 Jahren (SD ± 15) und Diagnose eines Morbus Basedow erhielten eine Radiojodtherapie. Insgesamt kam es bei 88,5 % nach der Behandlung zu einer Euthyreose oder Hypothyreose. Die Studie wurde vor Behandlung sowie 1, 3 und 6 Monate nach Radiojodtherapie (131I) durch einen einzelnen Untersucher dokumentiert. Das Volumen, die Echogenität, die Echotextur und die Vaskularisation der Drüsen sowie die maximale systolische Geschwindigkeit (PSV) der A. thyreoidea inferior wurden bewertet und mit den Laborergebnissen verglichen.

Ergebnisse Schilddrüsenvolumen und PSV zeigten eine statistisch signifikante Korrelation mit den Hormonspiegeln (p < 0,05). Das mittlere therapeutische Schilddrüsenvolumen vor Therapie betrug 43,01 ± 3,88 cm³ und lag 6 Monate nach Behandlung bei 11,58 ± 11,26 cm³. Die mittlere PSV vor Gabe von 131I betrug 90,06 ± 44,13 cm/s und nahm im zeitlichen Verlauf signifikant ab (p < 0,001). 6 Monate nach Therapie betrug die mittlere PSV 32,95 ± 16,36 cm/s. Es gab jedoch keinen signifikanten Zusammenhang zwischen den subjektiven Parametern und der Normalisierung der Schilddrüsenhormone.

Schlussfolgerung Doppler-US zeigte sich für die Bewertung des Schilddrüsenvolumens und der maximalen systolischen Geschwindigkeit bei der Überwachung des therapeutischen Ansprechens von Morbus-Basedow-Patienten auf die Radiojodtherapie von Nutzen.

Key words

thyroid gland - hyperthyroidism - Graves’ disease - duplex-doppler ultrasound - radioiodine therapy (131I)
 

  • References

  • 1 Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res 2012; 54: 204-213
    CrossrefPubMedGoogle Scholar
  • 2 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid 2016; DOI: 10.1089/thy.2016.0229.
    CrossrefPubMedGoogle Scholar
  • 3 Bartalena L, Masiello E, Magri F. et al. The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: Results of a large observational longitudinal study. J Endocrinol Invest 2016; DOI: 10.1007/s40618-016-0516-7.
    CrossrefPubMedGoogle Scholar
  • 4 de Vieira LO, Kubo R, Sapienza MT. et al. Correlation between thyroid volume determined either by ultrasound or by scintigraphy and its implications in dosimetric radioiodine calculations in Graves disease treatment. Arq Bras Endocrinol Metabol 2011; 55: 696-700
    CrossrefPubMedGoogle Scholar
  • 5 Lang BHH, Woo YC, Wong IYH. et al. Single-session high-intensity focused ultrasound treatment for persistent or relapsed Graves disease: Preliminary experience in a prospective study. Radiology 2017; DOI: org/10.1148/radiol.2017162776.
    CrossrefPubMedGoogle Scholar
  • 6 Maia AL, Scheffel RS, Meyer EL. et al. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol 2013; 57: 205-232
    CrossrefPubMedGoogle Scholar
  • 7 Sapienza MT, Coura-Filho GB, Willegaignon J. et al. Clinical and dosimetric variables related to outcome after treatment of Graves’ Disease with 550 and 1110 mbq of 131I: Results of a prospective randomized trial. Clin Nucl Med 2015; 40: 715-719
    CrossrefPubMedGoogle Scholar
  • 8 Chen L, Zhao X, Liu H. et al. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis. J Int Med Res 2012; 40: 640-647
    CrossrefPubMedGoogle Scholar
  • 9 Zuhur SS, Ozel A, Kuzu I. et al. The diagnostic utility of color doppler ultrasonography, Tc-99m pertechnetate uptake and TSH receptor antibody for diferential diagnosis between Graves disease and silent thyroiditis: a comparative study. Endocr Pract 2013; 20: 310-319
    CrossrefPubMedGoogle Scholar
  • 10 Alzahrani AS, Ceresini G, Aldasouqi SA. Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool. Endocr Pract 2012; 18: 567-578
    CrossrefPubMedGoogle Scholar
  • 11 Donkol RH, Nada AM, Boughattas S. Role of color Doppler in differentiation of Graves’ disease and thyroiditis in thyrotoxicosis. World J Radiol 2013; 5: 178-183
    CrossrefPubMedGoogle Scholar
  • 12 Kumar KV, Vamsikrishna P, Verma A. et al. Utility of colour Doppler sonography in patients with Graves’ disease. West Indian Med J 2009; 58: 566-570
    PubMedGoogle Scholar
  • 13 Pishdad P, Pishdad GR, Tavanaa S. et al. Thyroid ultrasonography in differentiation between Graves’ Disease and Hashimoto’s Thyroiditis. J Biomed Phys Eng 2017; 7 (1)
    PubMedGoogle Scholar
  • 14 Varadhan L, Varughese GI, Sankaranarayanan S. Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?. Indian J Endo and Metabolism 2016; DOI: 10.4103/2230-8210.192899.
    CrossrefPubMedGoogle Scholar
  • 15 Solbiati L, Rizzatto G, Charboneau JW. Ultrasound of superficial structures: High frequencies, doppler and interventional procedures. New York: 1995
    PubMedGoogle Scholar
  • 16 Vitti P, Rago T, Mazzeo S. et al. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis. J Endocrinol Invest 1995; 18: 857-861
    CrossrefPubMedGoogle Scholar
  • 17 Ralls PW, Mayekawa DS, Lee KP. et al. Color flow Doppler sonography in Graves’ disease: “thyroid inferno”. Am J Roentgenol 1988; 150: 781-784
    CrossrefPubMedGoogle Scholar
  • 18 Zuhur SS, Ozel A, Velet S. et al. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves’ disease? A prospective study. Clinics 2012; 67: 125-129
    CrossrefPubMedGoogle Scholar
  • 19 Karakas O, Karakas E, Cullu N. et al. An evaluation of thyrotoxic autoimmune thyroiditis patients with triplex Doppler ultrasonography. Clin Imaging 2014; 38: 1-5
    CrossrefPubMedGoogle Scholar
  • 20 Zhao X, Chen L, Li L. et al. Peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis. PLoS One 2012; 7 (11) e50051
    CrossrefPubMedGoogle Scholar
  • 21 Caruso G, Attard M, Caronia A. et al. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases. Eur J Radiol 2000; 36: 5-10
    CrossrefPubMedGoogle Scholar
  • 22 Menconi F, Marcocci C, Marino M. Diagnosis and classification of Graves’ disease. Autoimmun Rev 2014; 13: 398-402
    CrossrefPubMedGoogle Scholar
  • 23 Ueda M, Inaba M, Kumeda Y. et al. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves’ disease relapse. Clinical Endocrinology 2005; 63: 657-662
    CrossrefPubMedGoogle Scholar
  • 24 Ballal S, Soundararajan R, Bal C. Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population. Indian J Med Res 2017; 145: 358-364
    PubMedGoogle Scholar
  • 25 Mizokami T, Hamada K, Maruta T. et al. Painful radiation thyroiditis after 131I therapy for Graves’ Hyperthyroidism: Clinical features and ultrasonographic findings in five cases. Eur Thyroid J 2016; 5: 201-206
    CrossrefPubMedGoogle Scholar
  • 26 Chen Y, Xie SP, He F. et al. Evaluation of the efficacy of standardized uptake value (SUV)-shape scheme for thyroid volume determination in Graves’ Disease: A comparison with ultrasonography. Asia Ocean J Nucl Med Biol 2017; 5: 44-48 . doi:10.22038/aojnmb.2016.7401
    PubMedGoogle Scholar
  • 27 Markovic V, Eterovic D. Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves’ disease. J Clin Endocrinol Metab 2007; 92: 3547-3552
    CrossrefPubMedGoogle Scholar
  • 28 Weetman AP. Graves’ disease. N Engl J Med 2000; 343: 1236-1248
    CrossrefPubMedGoogle Scholar
  • 29 Castagnone D, Rivolta R, Rescalli S. et al. Color Doppler sonography in Graves’ disease: Value in assessing activity of disease and predicting outcome. Am J Roentgenol 1996; 166: 203-207
    CrossrefPubMedGoogle Scholar
  • 30 Peters H, Fischer C, Bogner U. et al. Reduction in thyroid volume after radioiodine therapy of Graves’ hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest 1996; 26: 59-63
    CrossrefPubMedGoogle Scholar
  • 31 Muller HW, Schroder S, Schneider C. et al. Sonographic tissue characterisation in thyroid gland diagnosis. A correlation between sonography and histology. Klin Wochenschr 1985; 63: 706-710
    CrossrefPubMedGoogle Scholar
  • 32 Höfling DB, Cerri GG, Juliano AG. et al. Value of thyroid echogenicity in the diagnosis of chronic autoimmune thyroiditis. Radiologia Brasileira 2008; 41: 409-417
    CrossrefPubMedGoogle Scholar
  • 33 Bogazzi F, Bartalena L, Brogioni S. et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7: 541-545
    CrossrefPubMedGoogle Scholar
  • 34 Bogazzi F, Bartalena L, Vitti P. et al. Color flow Doppler sonography in thyrotoxicosis factitia. J Endocrinol Invest 1996; 19: 603-606
    CrossrefPubMedGoogle Scholar
  • 35 Eising EG, Gorges R, Freudenberg L. et al. Influence of therapy with iodine-131 on thyroid tissue pattern in colour and power Doppler sonography. Clin Radiol 2002; 57: 646-651
    CrossrefPubMedGoogle Scholar
  • 36 Saleh A, Furst G, Feldkamp J. et al. Estimation of antithyroid drug dose in Graves’ disease: value of quantification of thyroid blood flow with color duplex sonography. Ultrasound Med Biol 2001; 27: 1137-1141
    CrossrefPubMedGoogle Scholar
  • 37 Macedo TA, Chammas MC, Jorge PT. et al. Reference values for Doppler ultrasound parameters of the thyroid in a healthy iodine-non-deficient population. Br J Radiol 2007; 80: 625-630
    CrossrefPubMedGoogle Scholar
  • 38 Macedo TA, Chammas MC, Jorge PT. et al. Differentiation between the two types of amiodarone-associated thyrotoxicosis using duplex and amplitude Doppler sonography. Acta Radiol 2007; 48: 412-421
    CrossrefPubMedGoogle Scholar
  • 39 Santos TARR, Pina ROG, Souza MTP. et al. Graves’ disease thyroid color-flow Doppler ultrasonography assessment: review article. Health. [Review] 2014; 6: 1487-1496
    CrossrefPubMedGoogle Scholar
  • 40 Kim TK, Lee EJ. The value of the mean peak systolic velocity of the superior thyroidal artery in the differential diagnosis of thyrotoxicosis. Ultrasonography 2015; 34: 292-296
    CrossrefPubMedGoogle Scholar
  • 41 Uchida T, Takeno K, Goto M. et al. Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients. Endocr J 2010; 57: 439-443
    CrossrefPubMedGoogle Scholar
  • 42 Nagasaki T, Inaba M, Fujiwara-Ueda M. et al. Thyroid blood flow as a useful predictor of relapse of Graves’ disease after normal delivery in patients with Graves’ disease. Biomed Pharmacother 2009; 64: 113-117
    CrossrefPubMedGoogle Scholar
  • 43 Nagasaki T, Inaba M, Kumeda Y. et al. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves’ disease. Biomed Pharmacother 2007; 61: 472-476
    CrossrefPubMedGoogle Scholar
  • 44 Ozturk M, Yildirim R. The usefulness of strain wave elastography in the diagnosis and grading oj Hashimoto’s thyroiditis in children. Radiol Med 2017; 122: 960-966 . doi:10.1007/s11547-017-0801-3
    CrossrefPubMedGoogle Scholar
  • 45 Dighe M, Barr R, Bojunga J. et al. Thyroid ultrasound: state of the art part 1 – thyroid ultrasound reporting and diffuse thyroid disease. Med Ultrason 2017; 19: 79-93 . doi:10.11152/mu-980
    PubMedGoogle Scholar
  • 46 Cosgrove D, Barr R, Bojunga J. et al. WFUMB guidelines and recommendations on the clinical use of ultrasound elastography: part 4. thyroid. Ultrasound Med Biol 2017; 43: 4-26 . doi:10.1016/j.ultrasmedbio.2016.06.022
    CrossrefPubMedGoogle Scholar